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Zinc-imidazolate polymers (ZIPs) as a potential
carrier to brain capillary endothelial cells†
M. Chiacchia,*a C. Cerutti,b R. Gromnicova,b K. Rietdorf,b I. A. Romerob and
D. Bradshaw*a
Herein, we report the synthesis and characterization of nanospheres of a biodegradable zinc-imidazolate
polymers (ZIPs) as a proof-of-concept delivery vehicle into human brain endothelial cells, the main component
of the blood-brain barrier (BBB). The ZIP particles can readily encapsulate functional molecules such as
fluorophores and inorganic nanoparticles at the point of synthesis producing stable colloidal dispersions.
Our results show that these biodegradable particles are not cytotoxic, and are able to penetrate and
release cargo species to human brain capillary endothelial cells in vitro thus exhibiting significant potential
as a novel platform for brain targeting treatments.
Introduction
Brain disorders have an enormous impact in societal and
economic terms, and constitute a major public health problem
in all high-income countries which is set to grow with increasingly
ageing populations.1,2 Many neurodegenerative disorders including
Alzheimer’s, Multiple Sclerosis and Ischemia are largely aggravated
from the weakening of the blood brain barrier (BBB), which is
formed by the brain capillary endothelium composed of dense
tight junctions between adjacent brain endothelial cells and is
responsible for blocking harmful substances from entering the
brain while allowing controlled access to necessary regulating
compounds.3,4 Direct actions to prevent or correct BBB dysfunction
in such diseases is challenging, but potential target treatments to
the brain endothelium can be of primary importance to prevent the
progression of many neurological diseases oﬀering the possibility
to reduce long-term illness.3,4
In recent years, the use of nanoparticles (NPs) as drug delivery
vectors have become the subject of extensive investigations for the
treatment of neurological disorders.5 NPs can play an essential role
in delivery across the BBB, and platforms based on liposomes,6 solid
lipids,7 dendrimers,8 and polymeric particles9 bearing high loadings
of therapeutic agents have all been utilised with varying degrees of
success. The chemistry, structure and physical properties including
size and surface charge of the NPs determine their potential for
reaching the brain, and despite their diverse compositions and the
ready ability to modify NP surfaces, each delivery platform has its
own limitations such as accumulation within the brain endothelium
that may lead to possible long-term toxicity and adverse eﬀects.10,11
Consequently, the formulation of new delivery platforms that allow
enhanced uptake of therapeutics by the brain endothelium which
minimise long term accumulation and do not compromise its
barrier function are paramount to meet the increasing demands
for the treatment of neurological diseases.10,11
Among the currently available nanodelivery systems, micro-
porous metal organic frameworks (MOFs) have significant promise
because of their high porosity, tailorable chemistry and in some
cases biocompatibility.12–17 The vast majority of MOFs investigated
for bio-delivery are crystalline in nature, and there remain fewer
studies on the cellular uptake and drug delivery properties of
their amorphous counterparts, which are often termed infinite
coordination polymers (ICPs).18–20 ICPs exhibit several properties
which separate them from conventional MOFs including a spherical
shape, facile size control and occasionally metastable behaviour.18–21
They are typically prepared by triggered precipitation22 or in
microemulsion-based systems23 where particle formation occurs
within surfactant-stabilised emulsion droplets. They can be readily
dispersed in a variety of media and their amorphous structures
tend to disassemblemore favourably in the presence of competitive
ligands than their crystalline counterparts. Amorphous MOFs can
also be obtained via post-synthetic reconstructive phase transitions
starting from crystalline frameworks, although these methods
typically result in particles of wide size distribution with random
shapes often observed at the microscale level.24–30 With regard to
nanodelivery applications, amorphous zirconium(IV)-based MOFs
have been shown to permit a sustained drug release when
compared with crystalline MOFs of the same composition.31
To further fulfil the potential of amorphous MOFs as drug
delivery systems for ameliorative therapies, it is desirable to
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conduct their syntheses in water to eliminate the presence of
potentially harmful organic solvents while simultaneously
yielding a uniform particle size. The choice of non-toxic metal
ions and organic ligands is also important to reduce the
footprint in biological systems, since these particles will break
down to a degree in biological milieu. Herein, we report the
direct synthesis of a zinc-imidazolate polymer (ZIP) under
highly dilute aqueous conditions to yield uniformly sized nano-
spheres that can readily encapsulate fluorophores and inorganic
NPs at the point of synthesis with extremely high loading
eﬃciencies. We have evaluated whether the loaded ZIP particles
could be used to potentially deliver therapeutic cargos to the
human brain endothelium using the immortalized hCMEC/D3
human cerebral microvascular endothelial cell line, a well-
established in vitro functional model for the human BBB, which
expresses the same levels of transporters, cell-specific receptors
and tight junction proteins found in healthy human brain
microvessels (Fig. 1).32,33 Our results demonstrate the bare ZIP
particles are stable in cell culture medium and are able to
penetrate the hCMEC/D3 brain endothelial cells membrane to
release their cargos within the cell cytoplasm.
Experimental section
Synthesis of ZIP particles
In a typical synthesis, 0.055 g of Zn(NO3)26H2O (1.85 mM) is
dissolved in 10 mL of deionized water and added to a solution
consisting of 0.911 g of 2-MeIm (111 mM) and 0.911 g of
1-MeIm (111 mM) in 90 mL of deionized water. The final molar
composition of the synthesis solution was Zn2+ : 2-MeIm :
1-MeIm:water = 1 :60 : 60 : 30054. The mixture was briefly mixed
and allowed to react at room temperature without stirring. The
mixture turned cloudy after 15min and a suspension was obtained.
After 24 h, the suspension was centrifuged and washed three
times with deionized water. The product was then freeze-dried
for 24 h. The yield is 30% based on the molar amount of zinc.
Preparation of RhB@ZIP particles
The synthesis of RhB@ZIP particles is based on the aforementioned
synthesis of ZIP particles. For a typical synthesis, 0.2 mL of a
1 mg mL1 rhodamine B solution in water were added to the
zinc solution and then mixed with a solution of 2-MeIm and
1-MeIm. After centrifugation the final solid showed an intense
magenta colour and a clear supernatant was obtained.
Preparation of AuNP@ZIP particles
AuNP@ZIP particles were synthesized under same experimental
conditions of the RhB-loaded ZIP material described above. The
synthesis of PVP-stabilized Au NPs (13 nm in size) was based on
a published procedure without any changes.34 0.18 mL of Au NPs
PVP-stabilized Au NPs (13 nm in size) were mixed with the zinc
solution and then added to the imidazole solution. After workup,
a pinkish solid was collected.
Cargo release kinetics of loaded-ZIP particles
RhB@ZIP and AuNP@ZIP particles were suspended in Hank’s
balanced salt solution (HBSS) pH 7.4, sodium acetate buﬀer
(NaOAc) pH 5.2 and Endothelial Cell Basal Medium-2 (EBM-2)
culture medium (Lonza) pH 7.4 without phenol-red and with
2.5% Fetal Bovine Serum (FBS) solution + supplements at 37 1C.
At specific set points of time, the solid was separated and 2 mL
aliquots of supernatant solution was withdrawn for fluorescence
measurements. The fluorescence intensity of the supernatant
solutions were measured using a Cary Eclipse fluorescence
spectrophotometer (Agilent, Santa Clara, CA) at lex = 540 nm
and lem = 577 nm. All measurements were performed in
triplicate. The withdrawn solutions were replaced with 2 mL of
fresh medium each time, in order to maintain sink conditions
throughout the experiment.
MTT Cytotoxicity assay of ZIP particles
hCMEC/D3 cell monolayers were seeded in 96-well plates at a
density of 30 000 cells per well and cultured for 2 days in EBM-2
medium. The cell monolayers were washed three times in HBSS
and incubated with medium containing ZIP particles at diﬀerent
concentrations (0, 2, 4, 6, 8, 16, 25 mg mL1) and times (0, 1, 3, 6,
12, 24 h). Then, medium with 0.5 mg mL1 of MTT reagent
(3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide)
was transferred to each well. After 4 h of incubation, the medium
was removed, and the cells were mixed with 0.1 mL of dimethyl-
sulfoxide (DMSO) and the plate carefully shaken for 10 min prior
to reading the absorbance at 540 nm using a FLUOstar Optima
plate reader (BMG LABTECH, Tampa, USA). All treatments were
performed in triplicate. Cell toxic agent digitonin (30 mg mL1
for 30 min) was used as a positive control, untreated cells
without ZIP particles as a negative control and wells with cell
medium only as a blank (Fig. S16, ESI†).
Cell culture and intracellular uptake studies
The immortalized human brain endothelial cell line hCMEC/
D3 was cultured in Endothelial Cell Basal Medium-2 (EBM-2)
culture medium (Lonza) as previously described.35 hCMEC/D3
Fig. 1 Synthesis and assembly of loaded ZIP particles and their uptake into
human brain endothelial cells. (I) Encapsulation process of cargo species
into the ZIP matrices at the point of synthesis. (II) Cross-section of the
human cerebral microvasculature and cell-uptake of loaded ZIP particles by
the isolated and immortalized human brain endothelial cell line.
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cells were grown on either collagen-coated 96-well plates or on
permeable polyester 12-well transwell inserts (0.4 mm pore,
12 mm diameter; Corning Costar, Buckingham, UK) coated
with Collagen Type I from calf skin and treated with loaded-ZIP
particles at the times and concentrations indicated for each
experiment. Cultures were maintained in an incubator at 37 1C
under an atmosphere of 5% CO2 and 90% relative humidity.
hCMEC/D3 cells were used in passages 25–30. Measurement of
RhB@ZIP particles taken up by hCMEC/D3 cells was performed
in a 96-well plate format. hCMEC/D3 cell were seeded in 96-well
plates at density of 30 000 cells per well and cultured for 2 days
in EBM-2medium. The cell monolayers were washed three times in
HBSS and incubated with medium containing RhB@ZIP particles
at different concentrations (0, 2, 4, 6, 8, 16, 25 mg mL1) and times
(0, 1, 3, 6, 12, 24 h). After three washes with HBSS, the fluorescence
intensity of RhB within the cells was measured using a FLUOstar
Optima fluorescence plate reader (BMG LABTECH, Tampa, USA)
lex = 540 nm and lem = 577 nm (Fig. S18 and S19, ESI†). Wells with
hCMEC/D3 cells only were used to determine the autofluorescence
of cells and subtracted from the measured fluorescence intensity.
The software Optima version 2.00R3 (BMG LABTECH, Tampa, USA)
was used to acquire and analyse the data. For AuNP@ZIP uptake
studies, hCMEC/D3 cells (70000 cells per well) were seeded on
collagen-coated 12-well transwell inserts (Corning Costar). The cell
monolayers were washed three times in HBSS and a well dispersed
solution of AuNP@ZIP particles were added in fresh culture
medium (0.5 mL) in the upper chamber for 3 h, 12 h and 24 h
at 4 mg mL1 and 6 mg mL1 at 37 1C. After three washes with
HBSS cells were fixed in 2.5% glutaraldehyde prepared in 0.1 M
So¨rensons phosphate buffer (PB) for 1 h at room temperature. The
cultures were then washed three times in phosphate buffer saline
(PBS) and stored in PBS at 4 1C before further processing for
electron microscopy.
In vitro imaging study
In vitro imaging was performed on live hCMEC/D3 cell monolayers
seeded in a Ibidis m-Slides VI system consisting of 6 parallel
channels (Ibidi GmbH) and incubated with RhB@ZIP particles
for 3, 12 and 24 h at concentrations of 4 mgmL1 and 6 mgmL1. At
the indicated times, cell nuclei were stained with Hoechst 33342
(1 mg mL1) for 10 min at 37 1C. The cells were then washed three
times in HBSS and observed using a fluorescent microscope at
magnification of 63 and 100 (Leica System-Leica AF6000 Series)
(Fig. S21, ESI†). Supporting movies of live hCMEC/D3 cell mono-
layers incubated with 6 mg mL1 of RhB@ZIP particles for 1 h were
also recorded with a speed of 0.5 frames per second (fps).
Results and discussion
In a typical experiment, ZIPs were synthesized by mixing
aqueous solutions of zinc nitrate, 2-methylimidazole (2-MeIm)
and 1-methylimidazole (1-MeIm) under conditions of very high
dilution at room temperature forming a stable colloidal disper-
sion (Fig. S1, ESI†). Scanning electron microscopy (SEM) and
transmission electron microscopy (TEM) images of the white
product recovered by centrifugation after 24 h reaction time at
room temperature reveal monodisperse spherical particles of
diameter 143  33 nm (Fig. 2a–d and Fig. S2, S3, ESI†), and a
comparable size distribution to other ICPs.18–20 The poly-
dispersity index (PDI) for the particles was 0.07, indicating a
good degree of homogeneity of the nanospheres.
The powder X-ray diﬀraction (PXRD) pattern of the ZIP
particles (Fig. S4, ESI†) shows no Bragg diﬀraction in the
angular range examined, with a single broad peak caused by
diﬀuse scattering which is consistent with an amorphous
material. This was further confirmed by solid state 13C NMR,
where the three resonances at 14.4, 124.3 and 151.5 ppm,
corresponding to the 2-MeIm framework-forming linker were
significantly broader than a crystalline control of identical
composition (Fig. S5, ESI†). This is entirely consistent with an
anisotropic and highly disordered structure as observed by
PXRD, and further hints at the dynamic nature often associated
with amorphous materials and in particular with ICPs.
Results obtained by 1H-NMR following particle digestion in
hydrochloric acid, Infrared Spectroscopy (FT-IR) and Inductive
coupled plasma optical emission spectrometry (ICP-OES) (Fig. S6,
S7 and Table S1, ESI†) show that ZIP particles have a composition
of [Zn(2-MeIm)2], identical to crystalline zeolitic imidazolate frame-
work ZIF-8, which has previously been employed to deliver a
number of exogenous chemical species into cancer cells.36–39 The
absence of 1-MeIm in the ZIP particles as confirmed by 1H-NMR
suggest that 1-MeIm can modulate the rate of reaction between the
zinc centres and 2-MeIm through weak coordination interactions
via a deprotonated amino group as reported for previous ZIF-8
preparations.40 The ZIP particles are thermally stable, decom-
posing in a single step at 380 1C, and have a BET surface area of
46  5 m2 g1 (Table S2, ESI†). While the porosity is expectedly
lower than crystalline ZIF-8 phases, it is entirely consistent with
Fig. 2 (a–c) TEM and SEM images of as-synthesized ZIP particles. Scale
bars = 500 nm. (d) Particle size distribution of ZIP particles, d = 143  33;
PDI = 0.07.
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experimental measurements previously reported for post-
synthetically amorphized ZIF-8 obtained via reconstructive
phase transitions induced by ball milling, high temperature or
high pressure.24,41 The z-potential of bare ZIP particles dispersed
in cell growthmedium is28 2.5 mV (Table S3, ESI†), which is
similar to other nanoscale ICPs and ZIFs measured in cell
medium and employed in cell uptake and drug delivery studies,14
and pegylated silica NPs that have recently been reported to cross
the BBB both in vitro and in vivo.10,42
The ZIP platform provides a facile means to load functional
molecules and NPs at the point of synthesis as previously
demonstrated for other ICP preparations, where these exogenous
species become fully incarcerated within the amorphous
matrix.19,21 This was demonstrated initially using two organic
fluorophores, rhodamine B (RhB) and fluorescein isothiocyanate
(FITC) as easily visualised model hydrophilic and hydrophobic
drug compounds, respectively. For RhB, loading was eﬀected by
simply adding the fluorophore to the aqueous synthesis mixture
yielding an intense magenta solid. Following removal of the
magenta solid (RhB@ZIP), fluorescence measurements on the
supernatant revealed a RhB loading eﬃciency in excess of 94%
(Fig. 3a) of the available dye.
Thermogravimetric analysis (TGA) and ICP-OES indicate a
total loading level of 2 wt% for RhB@ZIP (Fig. S8 and Table S1,
ESI†), which is progressively reduced when the fluorophore is
added later in the synthesis (23.5% and 15% incorporation
respectively, when RhB is added after 1 h and 5 h of ZIP
synthesis; Fig. S9, ESI†). This suggests that high loading levels
of the fluorophore can be incorporated into the amorphous
coordination matrix with minimal leaching, but only when
present at the start of ZIP synthesis. The z-potential of RhB@ZIP
(23  2.3 mV),39 indicates that the fluorophore is largely
immobilized within the ZIP matrix rather than being adsorbed
to its external surface, in good agreement with the leaching
studies. TEM images of RhB@ZIP reveal a similar size and
uniformity to the free ZIP nanospheres, indicating that the
presence of RhB does not interfere with the assembly of the
amorphous coordination-derived matrix (Fig. S10, ESI†), and
FT-IR and fluorescence microscopy further confirm the presence
of RhB. The same procedure was applied to encapsulate FITC,
but yielded ZIP particles of ill-defined morphology (Fig. S11,
ESI†). Under the pH conditions of the ZIP synthesis (pH 9–10)
the predicted theoretical surface charges for FITC and RhB are
1.80 and +0.23, respectively.43 The negative charge on the FITC
fluorophore suggests that it could ligate to Zn2+ during ZIP
assembly, which could disrupt the particle formation. This is
consistent with a recent report that crystalline ZIF-8 nanospheres
with a positive z-potential only encapsulate negatively-charged
guests,39 and indicates that the physical properties of the guest
are important to successful encapsulation and in the present
case framework morphology.
Encapsulation was also demonstrated with polyvinylpyrrolidone
(PVP) functionalized gold nanoparticles (Au NPs, d = 13 nm,
Fig. S12, ESI†) which themselves have been demonstrated to be
an eﬀective therapeutic platform.44 The presence of PVP on the
surface of the Au NPs increases their stability and enhances
their aﬃnity to the ZIP precursors.45 The ultraviolet-visible
(UV-vis) absorption spectrum of the recovered supernatant showed
no detectable localized surface plasmon resonance (LSPR) band for
Au, indicating all available Au NPs were incorporated into the ZIPs
which was determined as 1.9 wt% by ICP-OES (Table S1, ESI†).
TEM images reveal isolated monodisperse ZIP particles each
containing multiple non-aggregated Au NPs confined within the
amorphous matrix (Fig. 3b and Fig. S13, ESI†) and the PXRD
pattern of the composite reveals a very weak and broadened peak
at 2y = 381 associated with the h111i Au lattice plane (Fig. S14,
ESI†). Together, these results demonstrate that ZIP particles
are an excellent platform for eﬃcient encapsulation of small
functional molecules and nanoscale objects and thus have
potential as delivery vehicles in biological applications.
To assess their stability and release properties for potential
applications in biodelivery, RhB@ZIP particles were soaked for
24 h in complete cell culture medium and buﬀer solutions at
37 1C at biologically relevant pH values (Fig. 4a and Table S4,
ESI†). We find 41% RhB is released when the RhB@ZIP
particles are soaked for 24 h at 37 1C in Endothelial Growth
Basal Medium-2 (EBM-2) that includes 2.5% fetal bovine serum
(FBS) and all supplements required for optimal cellular growth
of hCMEC/D3 cells.32,33 A 24% RhB release was observed from
RhB@ZIP in Hank’s balanced salt solution (HBSS) at pH 7.4
over a period of 24 h. In the presence of sodium acetate buﬀer
(NaOAc) at pH 5.2 however, a progressive release occurred
during the first 6 hours of incubation reaching 90% in 24 h as
previously observed for drug release from some ICPs that are not
surface coated to protect the networks from erosion.19,21,46,47
Similar release kinetics have also been observed for AuNP@ZIP
particles in the presence of the cell culture medium and buﬀer
solutions (Fig. S15 and Table S4, ESI†).
Fig. 3 (a) Fluorescence spectra showing the encapsulation of RhB in
ZIP particles; inset shows the recovered magenta solid residue. Right
side: fluorescent image of disperse RhB@ZIP particles. Scale bar = 5 mm.
(b) UV-Vis spectra of PVP–Au NPs encapsulated in ZIPs; inset shows the
pink solid residue. Right side: TEM image of a single AuNP@ZIP nano-
sphere showing well dispersed and fully confined Au NPs within the ZIP
matrix. Scale bar = 100 nm.
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An accelerated degradation of the ZIP carrier at low pH
could possibly reduce the long-term risk of accumulation in the
brain endothelium and potentially prevent adverse eﬀects on its
natural barrier function. The cargo-release behaviour of the bare ZIP
particles compares well to the average release profiles of 20–50%
over 12–24 h reported for most crystalline MOF-based cargo delivery
systems when incubated in buffered media.36–39,48–50 Moreover the
ZIP particles show an improved and sustained release, most likely
facilitated by their zinc-imidazolate composition, when compared to
other (bare) ICPs in buffer solutions where an average release of up
to 80% in the first 12 h is typical.18,19,21,46,47
Prior to cellular uptake studies the cytotoxicity of empty ZIP
particles was evaluated against hCMEC/D3 brain endothelial
cells in vitro, by MTT toxicity assay. hCMEC/D3 cells were
exposed to a progressive concentration of ZIP particles (up to
a maximum 25 mg mL1) for 24 h. Minimal cytotoxicity of the
ZIP particles was observed at all doses and incubation times
tested (Fig. 4b and Fig. S16, ESI†). The pH of the EBM-2 culture
medium during cellular growth was also monitored for 24 h in
order to anticipate a possible premature acid-induced release of
the fluorophore from the loaded ZIPs outside the cells. We
found that the pH of the culture medium remains in the
optimum range (from pH 7.4 to 7.0) over the time-course of
the in vitro experiments (Fig. S17, ESI†) indicating this is
appropriate for the biodelivery experiments.
hCMEC/D3 endothelial cells were incubated in cell culture
medium containing RhB@ZIP particles (up to 25 mg mL1) over
a period of 24 h. After the required incubation period, cells
were washed with HBSS in order to remove non-internalized
particles. The amount of internalized RhB was evaluated by
recording the fluorescence intensity within the whole cells.
Increased fluorescence was readily observed after 1 h and 3 h
of incubation when compared to free RhB controls (Fig. 4c and
Fig. S18, ESI†). Notably, we observed an increased fluorescence
signal as both the incubation time and RhB@ZIP concentration
increased (Fig. S19, ESI†). The amount of free RhB used in the
control experiments was equivalent to the concentration that
would be expected to be released by the RhB@ZIP particles into
the medium over the time-course experiments as determined
from the release profiles shown in Fig. 4a. Thus for a concen-
tration of 6 mg mL1 of RhB@ZIP with a total RhB content of
120 ng mL1 (2 wt%), the amount that would be released into
the medium following 3 h of incubation is ca. 40 ng mL1.
Quantification of the cellular fluorescence intensity clearly
shows an average 3-fold increase of the RhB signal in the
hCMEC/D3 cell cytoplasm upon delivering the fluorophore
using RhB@ZIP particles compared to the free RhB controls.
The intracellular dissolution of RhB@ZIP particles and subse-
quent release of RhB in hCMEC/D3 cells was further explored
using live-cell fluorescent microscopy. Bright field images
clearly show live cells with no morphological alterations of
the typical spindle shape confirming the presence of a healthy
cell monolayer during the in vitro studies (Fig. S20, ESI†). The
fluorescent images and data suggest an enhanced cellular
uptake of the ZIP carrier compared to free RhB (Fig. 4d, e
and Fig. S21, ESI†) by the human brain endothelial cells across
the concentration range tested. Upon live-cell imaging the
RhB@ZIP particles were found to penetrate the endothelial cell
membrane following 1 h and 3 h of incubation, with high
intracellular traﬃcking observed in video-microscopy which
suggest that ZIP particles may use the endosomal entry route
(Movies S1 and S2, ESI†). Images also showed high diﬀuse
fluorescence within the cell cytoplasm which support the
hypothesis of a pH-induced dissociation of the metal–ligand
matrix along the endosomal pathway and subsequent release
of RhB.39 We note that brain endothelial cells highly express
P-glycoprotein (Pgp), an ATP-driven efflux pump which contributes
to the BBB defence mechanism by pumping out foreign mole-
cules.51–53 Thus the observed increase in fluorescence intensity
may also include a contribution from enhanced cellular retention
of the fluorophore in the presence of the carrier.
To evaluate the diversity of cargo that can be delivered to the
brain endothelial cells, AuNP@ZIP particles were incubated
with a brain endothelial cell monolayer for 3 h and 12 h, and
intracellular release investigated by TEM (Fig. S22, ESI†). Con-
trol samples with free Au NPs were performed following the
same procedure. We found that the Au NPs released from
AuNP@ZIP, while absent from cellular junctions, are localized
throughout the endothelial cell cytoplasm including in vesicles,
implying a vesicular transport process. We also observed that
many Au NPs accumulated in the extracellular space between
Fig. 4 (a) Kinetic release profiles of RhB from RhB@ZIP particles in diﬀerent
buﬀer solutions and cell culture medium at 37 1C. Sodium acetate (NaOAc)
pH 5.2 buﬀer solution; complete Endothelial Cell Basal Medium-2 (EBM-2)
culture medium pH 7.4 (without phenol-red); Hank’s balanced salt solution
(HBSS) pH 7.4 buﬀer solution. Data are displayed as mean  SD, (n = 3).
(b) Viability of human brain endothelial cells incubated with increasing
concentration of ZIP particles for 24 h. Negative control were untreated
cells (neg c) and digitonin-treated cells (dig, 30 mg mL1 for 30 min) were a
positive control for cell death, (n = 2). (c) RhB released in cells by RhB@ZIP
particles after 3 h incubation (background cell alone subtracted) vs. the
amount of free RhB corresponding to the expected quantity released from
the particles into the EBM-2 complete culture medium at 37 1C after the
same incubation period, (n = 3). (d) Fluorescent images showing cellular
uptake of free RhB (100 ng mL1) and (e) RhB released in the cells by
RhB@ZIP particles (4 mg mL1, total RhB contents = 80 ng mL1) both
following 3 h of incubation. In red, RhB fluorescence signal and in cyan, cell
nuclei stained with Hoechst 33342. Scale bar = 20 mm. All data shown are
mean  SEM and were analyzed by unpaired two-tail Student’s t-test, *Po
0.05, ** P o 0.01, ***P o 0.001, * significantly diﬀerent from the controls.
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the basal plasma membrane and the polyester membrane filter
of the transwell insert. The observed Au NP localisation within
the cells is in agreement with previous reports of BBB models
exposed to appropriately functionalised Au NPs.11,54,55 The
AuNP@ZIP composite would thus appear to facilitate the inter-
nalization of the Au NPs into the cytosol, and once released are able
to translocate inside the brain endothelial cells cytoplasm and exit
through the basal membrane without using the paracellular route.
The observed uptake of AuNP@ZIP particles and their intracellular
release within hCMEC/D3 is in agreement with the observations for
the RhB@ZIP.
Conclusions
We have reported the synthesis of biocompatible ZIP particles
in water that are able to encapsulate diverse cargo species with
great eﬃciency at the point of synthesis. The ZIP particles
clearly display marginal cytotoxicity when compared to control
samples, and are readily internalised by an in vitro BBB model
whereupon their cargo is released most likely via pH-induced
dissociation of the matrix. While the released RhB promptly
diﬀuses into the cell cytoplasm, ZIP particles also appear to
facilitate the delivery of Au NPs across the in vitro BBB. These
results indicate that bare ZIP particles have an appropriate size,
hydrophobic/hydrophilic balance and surface charge allowing
them to pass through the hCMEC/D3 human cerebral micro-
vascular endothelial cell membrane via an endocytic entry
route where their degradation and biologically benign compo-
sition could ensure minimum nanocarrier footprint in the
cells. More studies are needed with respect to the exact cellular
uptake mechanism, clearance rate and blood-stream stability of
the ZIPs, but nevertheless this study provides a step forward in
the formulation of potentially theranostic particles based on
coordination-derivedmatrices for delivery to the brain endothelium
and the treatment of related brain diseases and dysfunctions.
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